Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2018-06-30 AGM Information
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
2018 Notice of Meeting
AGM Information Classification · 100% confidence The document explicitly addresses the 'Annual General Meeting (Meeting)' and details the resolutions to be voted upon, including the approval of the Annual Report and Accounts, Directors' Remuneration Report, dividend recommendation, re-election of Directors, appointment of the Auditor, and authorities for share allotment and purchase. The introductory letter is dated September 10, 2018, and refers to the meeting scheduled for October 19, 2018. This content is characteristic of the materials sent to shareholders in advance of an AGM, which typically includes the Notice of Meeting and often the Annual Report itself, but the primary function of this specific document is to solicit votes and provide context for the AGM agenda. This aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings. While it discusses the Annual Report (Resolution 1), the document itself is the solicitation package for the AGM.
2018-06-30 English
2018 Annual Financial Report
Annual Report Classification · 100% confidence The document contains a comprehensive table of contents, financial highlights, strategic reports, board of directors information, and detailed financial statements (including independent auditor's report and consolidated income statements). The structure and content are characteristic of a full annual report for a public company, covering the entire fiscal year's performance and business operations. FY 2017
2018-06-30 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content details the 'Total Voting Rights' (102,329,635 ordinary shares) as of the announcement date (29 June 2018), referencing DTR 5.6.1R. This type of mandatory notification regarding the total number of shares with voting rights, which serves as the denominator for shareholder disclosure calculations, is a standard regulatory announcement. Since it is a specific regulatory notification that doesn't fit the more specific categories like Director's Dealing (DIRS) or Major Shareholding Notification (MRQ), and it is a direct regulatory update, the most appropriate classification is the general regulatory filing category, RNS. The document length is short (approx. 2500 chars), but it is a direct notification, not an announcement *about* another report, so RPA is less suitable than RNS for this specific regulatory disclosure.
2018-06-29 English
Blocklisting
Share Issue/Capital Change Classification · 99% confidence The document begins with an 'RNS Number' and is dated June 4, 2018. The content explicitly states that an application has been made to the Financial Conduct Authority and the London Stock Exchange for the admission of 71,000 ordinary shares under a block listing related to employee share schemes (Unapproved Share Scheme and LTIP). This is a formal regulatory announcement concerning the issuance of shares and capital structure change, distributed via RNS. While it relates to share capital, the primary nature is a regulatory notification of a listing/share issuance event, which aligns closely with 'Share Issue/Capital Change' (SHA). However, since it is explicitly distributed via RNS and is a short, specific regulatory update, it also fits the general 'Regulatory Filings' (RNS) category. Given the specific action is about admitting shares to the Official List, SHA is highly relevant. Let's check the definitions: SHA is 'Announcement regarding new share issues, stock splits, or other capital changes.' This fits perfectly as it details the reservation and admission of new shares. The document is short and is a direct announcement, not a detailed report, making SHA the most precise fit over RNS (which is the fallback).
2018-06-04 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document explicitly states 'RNS Number : 5531M' and notifies the market regarding the 'Total Voting Rights' as of the announcement date, referencing DTR 5.6.1R. This type of mandatory disclosure about the total number of shares with voting rights, used by shareholders for determining notification thresholds, is a standard regulatory announcement. While it relates to share capital, it is not a transaction (POS) or a general capital change (SHA), but rather a mandatory disclosure of the current denominator for transparency rules. Since it is a formal regulatory notification distributed via RNS, and it doesn't fit perfectly into the other specific categories like DIV or DVA (which is for voting *results*), the most appropriate classification is the general regulatory filing category, RNS, as it is explicitly branded as an RNS release.
2018-04-30 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states it is providing information 'in conformity with DTR 5.6.1R'. The core content announces the 'Total Voting Rights' as of the announcement date (April 3, 2018), specifying the total number of ordinary shares with voting rights (102,315,783). This type of mandatory disclosure regarding the total share capital used as a denominator for disclosure rules fits the definition of a general regulatory announcement. Since it is a specific regulatory notification that doesn't fit other categories like Director's Dealing (DIRS) or Major Shareholding Notification (MRQ), and it is clearly an RNS release, the most appropriate classification is Regulatory Filings (RNS). The document length is short (2185 chars), but the content is substantive regulatory data, not just an announcement *about* another report, making RNS more suitable than RPA.
2018-04-03 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.